vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是COMPASS MINERALS INTERNATIONAL INC的1.2倍（$493.8M vs $396.1M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs 4.7%，领先2.1%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs -1.7%），过去两年COMPASS MINERALS INTERNATIONAL INC的营收复合增速更高（4.3% vs -0.1%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
CMP vs MD — 直观对比
营收规模更大
MD
是对方的1.2倍
$396.1M
营收增速更快
CMP
高出30.6%
-1.7%
净利率更高
MD
高出2.1%
4.7%
两年增速更快
CMP
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $493.8M |
| 净利润 | $18.6M | $33.7M |
| 毛利率 | 16.0% | — |
| 营业利润率 | 9.2% | 9.9% |
| 净利率 | 4.7% | 6.8% |
| 营收同比 | 28.9% | -1.7% |
| 净利润同比 | 178.8% | 10.5% |
| 每股收益（稀释后） | $0.43 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPMD
| Q4 25 | $396.1M | $493.8M | ||
| Q3 25 | $227.5M | $492.9M | ||
| Q2 25 | $214.6M | $468.8M | ||
| Q1 25 | $494.6M | $458.4M | ||
| Q4 24 | $307.2M | $502.4M | ||
| Q3 24 | $208.8M | $511.2M | ||
| Q2 24 | $202.9M | $504.3M | ||
| Q1 24 | $364.0M | $495.1M |
净利润CMPMD
| Q4 25 | $18.6M | $33.7M | ||
| Q3 25 | $-7.2M | $71.7M | ||
| Q2 25 | $-17.0M | $39.3M | ||
| Q1 25 | $-32.0M | $20.7M | ||
| Q4 24 | $-23.6M | $30.5M | ||
| Q3 24 | $-48.3M | $19.4M | ||
| Q2 24 | $-43.6M | $-153.0M | ||
| Q1 24 | $-38.9M | $4.0M |
毛利率CMPMD
| Q4 25 | 16.0% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 19.2% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 19.7% | — |
营业利润率CMPMD
| Q4 25 | 9.2% | 9.9% | ||
| Q3 25 | 5.3% | 13.8% | ||
| Q2 25 | 7.4% | 12.8% | ||
| Q1 25 | -0.6% | 7.0% | ||
| Q4 24 | 0.2% | 7.8% | ||
| Q3 24 | -14.3% | 6.6% | ||
| Q2 24 | 2.9% | -31.3% | ||
| Q1 24 | -10.8% | 3.2% |
净利率CMPMD
| Q4 25 | 4.7% | 6.8% | ||
| Q3 25 | -3.2% | 14.5% | ||
| Q2 25 | -7.9% | 8.4% | ||
| Q1 25 | -6.5% | 4.5% | ||
| Q4 24 | -7.7% | 6.1% | ||
| Q3 24 | -23.1% | 3.8% | ||
| Q2 24 | -21.5% | -30.3% | ||
| Q1 24 | -10.7% | 0.8% |
每股收益（稀释后）CMPMD
| Q4 25 | $0.43 | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | $-0.41 | $0.46 | ||
| Q1 25 | $-0.77 | $0.24 | ||
| Q4 24 | $-0.57 | $0.37 | ||
| Q3 24 | $-1.17 | $0.23 | ||
| Q2 24 | $-1.05 | $-1.84 | ||
| Q1 24 | $-0.94 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $375.2M |
| 总债务越低越好 | $890.0M | $570.5M |
| 股东权益账面价值 | $260.5M | $865.9M |
| 总资产 | $1.5B | $2.2B |
| 负债/权益比越低杠杆越低 | 3.42× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资CMPMD
| Q4 25 | $46.7M | $375.2M | ||
| Q3 25 | $59.7M | $340.1M | ||
| Q2 25 | $79.4M | $224.7M | ||
| Q1 25 | $49.5M | $99.0M | ||
| Q4 24 | $45.8M | $229.9M | ||
| Q3 24 | $20.2M | $103.8M | ||
| Q2 24 | $12.8M | $19.4M | ||
| Q1 24 | $38.3M | $8.0M |
总债务CMPMD
| Q4 25 | $890.0M | $570.5M | ||
| Q3 25 | $839.8M | $577.2M | ||
| Q2 25 | $833.4M | $583.9M | ||
| Q1 25 | $807.6M | $590.5M | ||
| Q4 24 | $974.4M | $597.1M | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
股东权益CMPMD
| Q4 25 | $260.5M | $865.9M | ||
| Q3 25 | $234.1M | $890.7M | ||
| Q2 25 | $249.8M | $833.8M | ||
| Q1 25 | $236.5M | $789.2M | ||
| Q4 24 | $263.0M | $764.9M | ||
| Q3 24 | $316.6M | $732.5M | ||
| Q2 24 | $352.1M | $706.5M | ||
| Q1 24 | $400.4M | $856.2M |
总资产CMPMD
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.2B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.7B | $2.2B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.0B | ||
| Q1 24 | $1.7B | $2.2B |
负债/权益比CMPMD
| Q4 25 | 3.42× | 0.66× | ||
| Q3 25 | 3.59× | 0.65× | ||
| Q2 25 | 3.34× | 0.70× | ||
| Q1 25 | 3.41× | 0.75× | ||
| Q4 24 | 3.70× | 0.78× | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -15.1% | — |
| 资本支出强度资本支出/营收 | 5.8% | — |
| 现金转化率经营现金流/净利润 | -1.99× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $94.1M | — |
8季度趋势，按日历期对齐
经营现金流CMPMD
| Q4 25 | $-37.0M | $114.1M | ||
| Q3 25 | $-6.9M | $137.3M | ||
| Q2 25 | $21.8M | $137.2M | ||
| Q1 25 | $186.9M | $-117.5M | ||
| Q4 24 | $-4.1M | $133.0M | ||
| Q3 24 | $-12.7M | $91.8M | ||
| Q2 24 | $-6.8M | $107.0M | ||
| Q1 24 | $86.2M | $-125.2M |
自由现金流CMPMD
| Q4 25 | $-59.8M | — | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $172.9M | — | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | $-33.6M | — | ||
| Q2 24 | $-21.5M | — | ||
| Q1 24 | $56.2M | — |
自由现金流率CMPMD
| Q4 25 | -15.1% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | -8.4% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -10.6% | — | ||
| Q1 24 | 15.4% | — |
资本支出强度CMPMD
| Q4 25 | 5.8% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 8.2% | — |
现金转化率CMPMD
| Q4 25 | -1.99× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
